Health Information Center

Preclinical Models: Innovative solutions to accelerate drug discovery and development

Preclinical models are developed to test lead compounds for toxicity and efficacy. They are valuable tools to minimize development costs and reduce failures prior to commencement of human trials. Problems with traditional animal models such as cost, ethics, and suitability has prompted researchers to develop new models and systems to overcome such disadvantages. Continue reading ‘Preclinical Models – Innovative Solutions To Accelerate Drug Discovery And Development’ »

Oncothyreon, Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates.

Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of clinical success for each pipeline product. Every Competitor Report compares the company against its primary competitors by individual therapeutic indication. Continue reading ‘Oncothyreon, Inc.-Therapeutic Competitors’ »

Opticians & Optical Goods – Market Assessment

This Market Assessment report provides an analysis of the opticians and optical goods market, which includes spectacles, contact lenses and solutions, laser eye treatment, sight tests and general ophthalmic services. It updates a previous Opticians & Optical Goods Market Assessment report published in August 2008. ( http://www.bharatbook.com/detail.asp?id=83563&rt=Opticians-Optical-Goods-Market-Assessment.html )

The market suffered the impacts of the recession in 2009 and several sectors experienced falling revenues. The downturn was the first reversal in an upward sales trend that had lasted for some years. Expenditure by opticians and suppliers of optical goods in areas such as main media advertising also declined in 2009, compared with 2008, and this was probably due in part to the recession. However, a growing population — in particular, the number of adults aged 60 and over — meant that the number of NHS sight tests taken in the year to March 2009 increased over the corresponding period of 2007/2008 and helped to sustain income from this source of revenue. Continue reading ‘Opticians & Optical Goods – Market Assessment’ »

Pipeline Insight: Leukemias Underserved patient populations offer potential for market growth

Despite major advances in treatment in the last decade, a considerable percentage of the leukemia population still has high unmet needs. Some key oncology companies have entered the leukemias market fairly recently while others are pursuing late-phase development in this indication, hoping to exploit the commercial potential of patient subgroups underserved by existing treatment options. ( http://www.bharatbook.com/detail.asp?id=134190&rt=Pipeline-Insight-Leukemias-Underserved-patient-populations-offer-potential-for-market-growth.html ) Continue reading ‘Pipeline Insight Leukemias Underserved Patient Populations Offer Potential For Market Growth’ »

Liver Cancer – Drug Pipeline Analysis and Market Forecasts to 2016

This is an essential source of information and analysis on the global liver cancer market. The report identifies the key trends shaping and driving the global liver cancer market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global liver cancer sector. ( http://www.bharatbook.com/detail.asp?id=134332&rt=Liver-Cancer-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016.html ) Continue reading ‘Liver Cancer Market Is Very Strong With Clinical Development’ »

HTML clipboard

The Kenya Pharmaceuticals and Healthcare Report

Independent 5-year pharmaceutical and healthcare industry forecasts for Kenya. Original pharmaceutical and healthcare market research and pharmaceutical and healthcare sector trend analysis for the Kenyan pharmaceutical and healthcare industry. Competitive intelligence, Kenyan pharmaceutical and healthcare company rankings and SWOT analyses on international and domestic pharmaceutical and healthcare companies in the Kenyan market. ( http://www.bharatbook.com/Market-Research-Reports/Pharmaceuticals-Healthcare-Report-Kenya.html )

The Kenya Pharmaceuticals and Healthcare Report has been researched at source and features the latest available data and forecasts to end- covering drugs and healthcare expenditure, the prescription, OTC and generics markets, and foreign trade; company rankings and competitive landscapes including multinational and national drugs companies; and analysis of latest industry news, trends and regulatory developments. Kenya Pharmaceuticals and Healthcare Report provides industry professionals, market investors and corporate and financial services analysts with independent forecasts and competitive intelligence on the Kenyan pharmaceutical and healthcare industry.

Key Benefits of Report :

* Benchmark Independent 5-year Pharmaceutical and Healthcare Industry Forecasts on Kenya to test other views – a key input for successful budgeting and strategic business planning in the Kenyan pharmaceutical and healthcare market. Continue reading ‘Opportunities & Risks in the Kenyan Pharmaceutical and Healthcare Sector’ »

Argenta-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Argenta-Company Report’ »

Avexa Limited-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Avexa Limited-Company Report’ »

Astellas Pharma Canada, Inc.-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Astellas Pharma Canada, Inc.-Company Report’ »

Eye care value sales increased by 8% to reach EUR4 million in 2009. In eye care, standard eye care was the fastest-growing category, up by 9% to reach over EUR3 million. Consumers became increasingly savvy about the appropriate use of eye care, while the main target group for eye care still remained contact lens users.

Eye Care Products in Austria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change. Continue reading ‘Eye Care – Austria’ »